These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6311699)

  • 1. [Effect of suloctidil in the protection of the cerebral function].
    Nishi H; Kadowaki S; Endo N
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):37-46. PubMed ID: 6311699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective effect of suloctidil against cerebral hypoxia (author's transl)].
    Hori N; Nishi H; Katsuda N
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):655-65. PubMed ID: 6260603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of suloctidil on the reduced evoked potentials in brain slices in low glucose perfusate].
    Nishi H; Hori N; Katsuda N
    Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):321-33. PubMed ID: 6323287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of suloctidil on cerebral venous outflow in the dog (author's transl)].
    Nishi H; Ishibashi A; Horii D
    Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):117-26. PubMed ID: 6274771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of prostaglandins D2, E1 and I2 against cerebral hypoxia/anoxia in mice.
    Masuda Y; Ochi Y; Ochi Y; Karasawa T; Hatano N; Kadokawa T; Shimizu M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):282-9. PubMed ID: 3543699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug action on cerebral energy state during and after various hypoxic conditions.
    Benzi G; Arrigoni E; Dagani F; Marzatico F; Manzini A; Pastoris O; Villa RF
    Arch Int Pharmacodyn Ther; 1978 Dec; 236(2):234-51. PubMed ID: 747471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of suloctidil on cerebral circulation patterns of conscious rabbits.
    Rozza Dionigi A; Lanza E; Favalli L; Carminati GM; Piccinini F
    Arzneimittelforschung; 1986 Feb; 36(2):194-6. PubMed ID: 3008769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of suloctidil on the dynamics of the peripheral artery of the dog].
    Horii D; Ishibashi A; Sano F
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):67-78. PubMed ID: 6311700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as drug for the elderly.
    Montefusco O; Missale C; Govoni S; Rozzini R; Trabucchi M
    Pharmacol Res Commun; 1983 Mar; 15(3):317-27. PubMed ID: 6304786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hypoxic and anti-ischemic actions of indeloxazine hydrochloride and its optical isomers: possible involvement of cerebral energy metabolism.
    Shimizu-Sasamata M; Terai M; Harada M; Yamamoto M
    Arch Int Pharmacodyn Ther; 1993; 324():33-46. PubMed ID: 8297184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of suloctidil on the central and peripheral nervous systems].
    Nishi H; Watanabe T; Mori M
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of platelets and of fibrinolysis by venous occlusion in healthy volunteers and influence of suloctidil in comparison with placebo.
    Baele G; Bary JL; van Stalle F
    Arzneimittelforschung; 1983; 33(8):1203-5. PubMed ID: 6315025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible role of endogenously formed cerebral prostaglandins in the development of adaptive protection against cerebral hypoxia/ischemia in mice.
    Masuda Y; Ochi Y; Ochi Y; Kadokawa T
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):721-7. PubMed ID: 3448451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of "cerebroactive drugs" in a model of acute hypoxia.
    Grau M; Balasch J
    Gen Pharmacol; 1985; 16(1):37-41. PubMed ID: 2984087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro vasorelaxing activity of suloctidil.
    Calderon P; van Dorsser W; Geöcze von Szendroi K; De Mey JG; Roba J
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):101-13. PubMed ID: 3030204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suloctidil increases the rat brain cortex microvascular regeneration after a lesion.
    De Paermentier F; Heuschling P; Knoops B; Janssens De Varebeke P; Pauwels G; Laszlo De Kaszon-Jakabfalva C; Van den Bosch De Aguilar P
    Life Sci; 1989; 44(1):41-7. PubMed ID: 2464117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 2-allophanyl-2-allyl-4-valerolactone (valofan) on cerebral energy metabolism of rat in normoxia and hypobaric hypoxia.
    Traversa U; Florio C; Vertua R
    In Vivo; 1987; 1(3):147-50. PubMed ID: 2979778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the effects of endothelin-1 (ET-1) and endothelin-3 (ET-3) in brain hypoxia and on the participation of brain prostanoids in their actions.
    Nikolov R; Masuda Y; Kato H; Minato H; Semkova I; Maslarova J
    Methods Find Exp Clin Pharmacol; 1993; 15(6):371-5. PubMed ID: 8231456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of R(-)-1-(benzo[b]thiophen-5-yl)- 2-[2-(N,N-diethylamino)ethoxy]ethanol hydrochloride (T-588), a novel cerebral activator, against experimental cerebral anoxia.
    Ono S; Kitamura K; Maekawa M; Hirata K; Ano M; Ukai W; Yamafuji T; Narita H
    Jpn J Pharmacol; 1993 May; 62(1):81-6. PubMed ID: 8101887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of DM-9384, a novel pyrrolidone derivative, against experimental cerebral anoxia.
    Sakurai T; Hatanaka S; Tanaka S; Yamasaki T; Kojima H; Akashi A
    Jpn J Pharmacol; 1990 Sep; 54(1):33-43. PubMed ID: 2273646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.